Biotricity, Inc.
BTCY
$0.52
-$0.0099-1.87%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 13.27M | 12.62M | 12.24M | 12.06M | 11.63M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.27M | 12.62M | 12.24M | 12.06M | 11.63M |
| Cost of Revenue | 3.41M | 3.36M | 3.44M | 3.71M | 4.01M |
| Gross Profit | 9.86M | 9.26M | 8.80M | 8.36M | 7.62M |
| SG&A Expenses | 12.21M | 12.82M | 14.06M | 14.61M | 14.29M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.90M | 18.37M | 19.87M | 20.89M | 20.87M |
| Operating Income | -4.64M | -5.75M | -7.63M | -8.83M | -9.24M |
| Income Before Tax | -10.67M | -12.25M | -14.38M | -14.09M | -14.58M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.67 | -12.25 | -14.38 | -14.09 | -14.58 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.67M | -12.25M | -14.38M | -14.09M | -14.58M |
| EBIT | -4.64M | -5.75M | -7.63M | -8.83M | -9.24M |
| EBITDA | -4.63M | -5.74M | -7.62M | -8.82M | -9.23M |
| EPS Basic | -1.08 | -1.37 | -1.74 | -1.66 | -1.75 |
| Normalized Basic EPS | -0.60 | -0.77 | -0.99 | -1.08 | -1.05 |
| EPS Diluted | -1.08 | -1.37 | -1.74 | -1.66 | -1.75 |
| Normalized Diluted EPS | -0.60 | -0.77 | -0.99 | -1.08 | -1.05 |
| Average Basic Shares Outstanding | 70.33M | 55.08M | 41.38M | 35.97M | 35.26M |
| Average Diluted Shares Outstanding | 70.33M | 55.08M | 41.38M | 35.97M | 35.26M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.22% | -0.20% | -0.17% | -0.13% | -0.16% |
